All we need is one 'Elite' special person saved from certain death due to sepsis and the appropriate media attention with proper beatings for our bloated FDA, and we would be off to the races. Reasons for turning down EAP were beyond stupid (past failures?).
It's worth billions and should be getting all kinds of traction. What is the problem? Don't doctors who see the success of the filter buy stock? How can this not be getting exposure that should blow the lid off the stock price?
Someday soon this will fly. 2-10 B in a buy-out. SOC for just about every major indication with inflammation possibility. Someday folks on daily dialysis will get a bi-monthly filter to remove the stuff that dialysis alone does not remove and currently accumulates in the body. Mark this post.
Da's like pamerican360 doing their job 24/7 to warn the little guy away from speculative stock in a really sucky stock market. Folks, the last study, as small as it was, provides the handwritting on the wall for the future of this company. Sepsis and proof are difficult studies but time will come when a suspicion of infection in a hospital will be aggressively treated with the filter. Treat early before organs start to fail and the big ICU costs kick in. It will save lives and Billions$.
Time to buy is now when it is cheap. You know 'buy low,sell high'. Novel concept. Accumulate aggressively.
and not using it again; as in it didn't perform? Or, because there are no alternative treatments, they use it again and perhaps more agrressively; sooner and longer? Just asking. Sales do seem to be increasing.